Then, this is the segment with the strongest focus in Pfizer's pipeline. If we take a look at the top 10 products in 2023 ... at potential peak sales of the most important names recently launched ...

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare ...

The company's adjusted gross margin of 70% in Q3-24 reflects challenges from an unfavorable mix of COVID-19 products and royalty expenses but highlights ongoing cost control measures. Pfizer ...

Sales of PFE’s COVID Products Declining ... in 2025 and beyond. Pfizer expects 2025 to 2030 revenue CAGR to be approximately 6%. Pfizer is one of the largest and most successful drugmakers ...

We recently compiled a list of the 12 Most Reliable Dividend Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE ... is the growing ...